Rilonacept - PDFSEARCH.IO - Document Search Engine

Rilonacept
Results: 7

#	Item
1	FOR IMMEDIATE RELEASE Press Release Astellas to Pay $295 Million to Extend License of Regeneron’s VelocImmune® Antibody Technology through 2023 Tarrytown, NY and Tokyo, Japan – (July 28, 2010) –Regeneron Pharmaceu Add to Reading List Source URL: www.astellas.com Language: English - Date: 2010-07-28 00:50:35 Medicine Regeneron Immunology Pharmaceutical industry Astellas Pharma Monoclonal antibodies Pharmaceutical industry in India Rilonacept Biopharmaceutical Biotechnology Immunosuppressants Biology
2	FOOD AND DRUG ADMINISTRATION (FDA) Center for Drug Evaluation and Research (CDER) Arthritis Advisory Committee (AAC) Meeting FDA White Oak Campus, Building 31, The Great Room (Rm[removed]White Oak Conference Center, Silve Add to Reading List Source URL: www.fda.gov Language: English Clinical research Clinical pharmacology Therapeutics United States Public Health Service Center for Drug Evaluation and Research Regeneron Rilonacept Food and Drug Administration Pharmaceutical sciences Pharmacology
3	FOOD AND DRUG ADMINISTRATION (FDA) Center for Drug Evaluation and Research (CDER) Arthritis Advisory Committee (AAC) Meeting FDA White Oak Campus, Building 31, The Great Room (Rm[removed]White Oak Conference Center, Silve Add to Reading List Source URL: www.fda.gov Language: English Inborn errors of purine-pyrimidine metabolism Arthritis Gout Rheumatology Colchicine Rilonacept Non-steroidal anti-inflammatory drug Regeneron Febuxostat Chemistry Organic chemistry Uric acid
4	FOOD AND DRUG ADMINISTRATION (FDA) Center for Drug Evaluation and Research (CDER) Arthritis Advisory Committee (AAC) Meeting FDA White Oak Campus, Building 31, The Great Room (Rm[removed]White Oak Conference Center, Silve Add to Reading List Source URL: www.fda.gov Language: English Clinical research Regeneron Center for Drug Evaluation and Research Rilonacept Food and Drug Administration Pharmaceutical sciences Pharmacology
5	FOOD AND DRUG ADMINISTRATION (FDA) Center for Drug Evaluation and Research (CDER) Arthritis Advisory Committee (AAC) Meeting FDA White Oak Campus, Building 31, The Great Room (Rm[removed]White Oak Conference Center, Silve Add to Reading List Source URL: www.fda.gov Language: English Inborn errors of purine-pyrimidine metabolism Arthritis Gout Rheumatology Colchicine Rilonacept Non-steroidal anti-inflammatory drug Regeneron Febuxostat Chemistry Organic chemistry Uric acid
6	Food and Drug Administration Center for Drug Evaluation and Research Summary Minutes of the Arthritis Advisory Committee Meeting May 8, 2012 Location: Add to Reading List Source URL: www.fda.gov Language: English Rheumatology Regeneron Immunosuppressants Inborn errors of purine-pyrimidine metabolism Uric acid Rilonacept Gout Colchicine Food and Drug Administration Medicine Health Chemistry
7	Rilonacept Regeneron, INN-rilonacept Add to Reading List Source URL: www.regeneron.com Language: English - Date: 2012-02-08 13:32:03 Bioethics Clinical research Medical ethics Pharmacology Immunosuppressants Regeneron Rilonacept Cryopyrin-associated periodic syndrome Placebo Medicine Health Science

UPDATE